247 Heart failure Flashcards

1
Q

What is heart failure?

A

Heart failure = abnormality of the heart where patients demonstrate clinical signs because of an inability to sustain cardiac output.

  • Forward failure = inadequate cardiac output with normal filling pressures
  • Backward or CHF = Clinical signs as a consequence of excessive cardiac filling pressures but normal cardiac output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the signs consistent with presence of heart failure?

A
  • Tachypnoea, dyspnea, or respiratory distress
  • Exercise intolerance
  • Cyanosis
  • Weakness and lethargy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What PE findings indicate heart failure?

A
  • Heart murmur +/- Arrhythmia
  • Increased RR and effort with audible pulmonary crackles
  • Abdominal distension with fluid wave - jugular venous distension and/or hepatojugular reflux
  • Pallor and cold periphery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What diagnostic findings indicate cardiac disease?

A
  • X-Ray -> cardiomegaly with pulmonary venous congestion ad alveolar/interstitial pattern of lung parenchyma
  • > pleural effusion
  • > hepatic venous congestion on US or RSHF or pericardial effusion
  • > Hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is preload and how is it managed?

A

= the left ventricular end-diastolic pressure, which is the amount of ventricular stretch at the end of diastole. It is determined by the pressure which blood returns to heart from venous circulation and influences by size of ventricle.
- The adaptive mechanisms leads to fluid retention, causing an increase in filling venous circulation (i.e. preload).

Management = drugs reducing circulation volume (diuretics) and dilate veins (venodilators)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is afterload and how is it managed?

A

= the force resisting contraction of the myocardium.

  • Main determinant of afterload is resistance in vascular bed which the ventricle is ejecting
  • increased afterload -> inhibit ventricular ejection, reduce CO, increase myocardial work, and -> result in signs of poor perfusion.

Management = Vasodilators reduce systemic or pulmonary vascular resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How would impaired myocardial contractility cause heart failure?

A
  • impairment would cause signs of inadequate cardiac output

- positive inotropic drugs lead to increased contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do abnormalities (heart rate, myocardial disease) to cardiac filling cause heart disease?

A
  • The heart must have enough time and be flexible to allow adequate venous return to enter the ventricles during diastole
  • Diseases causing myocardium stiffness, impair relaxation (impair lusitropy), of insufficient time or space to fill compromise filling.
  • Lusiotropic drugs -> sympathomimetic agents and calcium channel blockers
  • Filling improved directly by modifying heart rate and rhythm so more time for ventricular relaxation and filling.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How would abnormality of heart rate and rhythm result in heart failure?

A
  • bradycardia -> drop CO due to drop in heart rate
  • tachycardia -> drop CO due to insufficient time to ventricles to fill and in some cases loss of normal coordinated patter of ventricular contraction (ventricular dyssynchrony)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the MOA of diuretics?

A
  • Result in excretion of sodium and reduce patients EFV.

- This lowers circulating fluid volume and reduction in preload.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the loop diuretics? MOA? Site of action? Max fractional excretion of sodium achieved?

A

= Furosemide and toresmide
MOA= blockade of Na/K/2Cl- carrier.
Action site= Loop of Henle
- up to 25% excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the thiazides? MOA? Site of action? Max fractional excretion of sodium achieved?

A

= hydrochlorothiazide
MOA= blockade of Na+/Cl- carrier
Action site = distal tubule and connecting segment
- 5% maximum fraction excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a potassium sparing diuretic? MOA? Site in nephron? Max fractional excretion?

A

= Spironolactone
MOA= blockade of aldosterone receptors
Site= cortical collecting tubule
- max fractional excretion 2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are complications of diuretic treatment?

A
  • volume depletion and reduced cardiac output=>result in hypotension and/or azotemia.
  • electrolyte abnormalities : RAAS and increased aldosterone in response to diuretic treatment result in attempting to retain sodium and increasing potassium loss => hypokalemia
  • hypotension - stimulates vasopressin release-> free water retention lead to expansion of circulating fluid and reduction of sodium concentration. => hypokalemia
  • signs of volume depletion and electrolyte abnormalities occur 10-14 days following diuretic regime. Check urea, creatinine, sodium, potassium, and chloride concentrations 10-14 day after initiation or alteration.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do venodilators do?

A

= dilate vessels.

  • This is used where preload reduction is required acutely.
  • Nitroglycerin administered cutaneously in an ointment .
  • N.B. Method of administration and development of tachyphylaxis (tolerance and rapid loss of efficacy) limit use of nitroglycerin to short periods of administration in hospitalised patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is nitroprusside?

A
  • rapid IV nitrate vasodilator
  • achieves preload reduction through venodilation, and afterload reduction through arterialisation
  • not practicle for primary care setting -> needs to be protected from UV light, not for chronic use, and metabolises to cyanide.
17
Q

What are the ACEi? What how do they work?

A
  • Enalapril, & benazepril
  • evidence for use in cats is not well established. One study showed ACEi were superior to. Beta blockers in treating HF secondary to myocardial disease
  • they inhibit angiotensin converting enzyme, to create vasodilation and inhibit fluid retention -> complementary effect with diuretics
18
Q

What are calcium channel blockers?

What do they do?

A

= amlodipine

  • Frequently used as an anti hypertensive agents in cacts with systemic hypertension- but marked arteriodilator effects lead to its use in dogs with heart failure. .
  • Reduces left atrial pressure in dogs with mitral regurgitation

= Diltiazam:
- Widely used as an antiarrhythmic agent and in cats as a possible positive lusitrope

19
Q

What are pulmonary vasodilators? How do they act?

A
  • Vasodilator acting specifically on pulmonary circulation

RSCHF:
- improve output from right side of heart and result in reduced systemic venous pressure due to effective transfer of blood from systemic veins into pulmonary arteries.

Sildenafil - phosphodiesterase V inhibitor
- most likely indicated in patents due to causes such as pulmonary vascular parasitic disease or chronic pulmonary disease or late stage MMVD when RSHF develops due to pulmonary hypertension

20
Q

What is dobutamine? How does it help? When is it indicated?

A

= sympathomimetic agent that acts primarily through stimulation of beta-1 receptors.

  • enhances force of myocardium contraction (inotropic) and rate of myocardium relaxation (lusitropic).
  • indicated in acute signs of heart failure complicated by hypotension or primary failure of myocardial contractility (i.e. DCM).
21
Q

What is pimobendan? When is it administered?

A
  • inotropic and vasodilatory effect
  • Phosphodiesterase inhibition and calcium sensitisation - broadly determined as inodilator
  • Inodilatory effects lead to enhanced cardiac output through reducing systemic vascular resistance and improved myocardial contractility.
  • indicated = Chronic treatment for MMV or DCM
  • Contraindicated = pericardial effusion causing tamponade, or left ventricular outflow obstruction
  • in cats it may be administered with ACEi and diuretic, particularly signs cardiac output with signs of congestion
22
Q

What do beta blockers do? When are they indicated?

A
  • used when increased sympathetic stimulation increases cardiac contractility and heart rate
  • Atenolol has been recommended for HCM, but recent studies suggest possible detrimental effect for cats with heart failure due to myocardial disease and neutral effect of atenolol on outcome of cats with preclinical myocardial disease
  • studies have also not shown improved effect on dogs with DCM and mitral valve disease.